Sam Ifergan is the Founder and Managing Partner of iGan Partners.
iGan Partners is the largest venture capital firm investing in Canada. They empower visionary founders with early-stage capital and the true resources required to grow extraordinary, high-impact companies in Healthcare Technology, Digital Therapeutics, Medical Devices, and Digital Health.
Takeaways
Investing at an early stage in medtech requires a deep understanding of the industry and the ability to navigate long development cycles and regulatory processes.
The Canadian healthcare system could benefit from greater adoption of Canadian technologies and increased support for early-stage companies.
Building and growing a medtech firm requires perseverance, a strong team, and a focus on adding value through expertise and resources.
Commercialization in medtech is a complex process that requires understanding reimbursement, clinical evidence, and the unique sales cycle in healthcare.
Chapters
00:00 Genesis of iGan Partners
01:25 Nuances of the MedTech Space
06:06 Investing at an Early Stage
08:38 The Importance of Imaging in Healthcare
11:29 Geography and Market Scale
13:08 Improving the Canadian Healthcare System
15:38 IP and Research in Canada
19:53 Building and Growing iGan Partners
20:58 Fund Size and Check Size in MedTech
22:30 Common Challenges in MedTech Companies
25:05 Exits and the MedTech Market
26:51 Fundraising Challenges in Canada
29:11 Key Trends in the MedTech Industry
30:15 Value Add and Support for Portfolio Companies
32:10 Commercialization Challenges in MedTech
34:07 Exciting Exits and Elevating the Talent Bar
37:14 The Cycle of MedTech Investments
38:27 Favorite Book and Excitement for the Future
40:14 Dealing with Hard Times
41:42 Message for Entrepreneurs
